Clinical Oncology Next-Generation Sequencing Market Growth or Demand Increase or Decrease for What Includes:
Rising global cancer burden boosts demand for precise genomic analysis, propelling clinical oncology next-generation sequencing market growth.
Continuous improvements in NGS technology are boosting the Clinical Oncology Next-Generation Sequencing Market. For example, Illumina’s NovaSeq platform will revolutionise cancer genome analysis by increasing sequencing speed and accuracy. This innovation propels market expansion by allowing for speedy and cost-effective genomic profiling in oncology research and clinical applications. The rising worldwide cancer burden, particularly in emerging countries, increases the need for accurate genomic analysis afforded by NGS. Thermo Fisher’s Oncomine tests, which provide full molecular profile, address this requirement by facilitating targeted therapy selection and monitoring, hence accelerating market expansion amid escalating cancer incidence estimates.
Clinical Oncology Next-Generation Sequencing Market CAGR Estimation:
The Clinical Oncology Next-Generation Sequencing market is expected to grow at a CAGR of 20.7% from 2024 to 2030, reaching nearly USD 35.42 Billion by 2030.
To Gain More Insights into the Market Analysis, Browse Summary of the Research Report @ https://www.maximizemarketresearch.com/request-sample/100383/
Clinical Oncology Next-Generation Sequencing Market Segmentation:
by Technology
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing
Others
by Workflow
Pre-Sequencing
Sequencing
Data Analysis
by Application
Screening
Diagnostics
Clinical Oncology Next-Generation Sequencing Market Overview:
Clinical Oncology Next-Generation Sequencing (NGS) is a high-throughput genomic study used to identify tumour DNA alterations and guide personalised cancer therapy by simultaneously examining many genes. Technological advancements, rising cancer prevalence worldwide, and rising need for personalised medicine are driving the Clinical Oncology Next-Generation Sequencing Market. Next-Generation Sequencing technologies, which offer higher throughput, faster turnaround times, and lower prices than previous sequencing methods, have become vital tools in oncology research and clinical treatment.
Eager to discover what’s within? Secure your sample copy of the report today: https://www.maximizemarketresearch.com/request-sample/100383/
Clinical Oncology Next-Generation Sequencing Market: Which Regions are Experiencing Growth or Increased Demand?
North America dominates the clinical oncology next-generation sequencing market.
Several significant variables contribute to North America’s dominance in the Clinical Oncology Next-Generation Sequencing (NGS) market. The region’s dominance is highlighted by regulatory measures in the United States focused at improving cancer screening diagnosis, including as the National Cancer Institute’s Cancer Genome Atlas programme, which has performed NGS on over 20,000 cancer samples from diverse types of the disease. The regulatory emphasis on early detection and diagnosis increases demand for clinical oncology NGS technologies.
The Clinical Oncology NGS market in Asia Pacific is expected to grow rapidly, owing to the burgeoning healthcare and pharmaceutical sectors, particularly in emerging countries. The region, particularly Australia and New Zealand, faces high cancer mortality rates, which drives need for advanced diagnostic technologies such as NGS. China, in particular, has seen a significant drop in sequencing costs, promoting economic development and market expansion.
Clinical Oncology Next-Generation Sequencing Market Scope and Methodology:
The Global Clinical Oncology Next-Generation Sequencing Market study includes detailed analysis. It provides an overview of the key local markets and their potential growth over the forecast period, as well as inearch thoroughly expsights on current market trends.
The reslores major market determinants, constraints, vendor possibilities and challenges, and the competitive landscape to help stakeholders make better decisions for increased profits. In addition to pricing data, major competitors, and regional analysis, the Clinical Oncology Next-Generation Sequencing market research covers international regions and nations, providing information on their growth status, market size, volume, and value.
For further information, click the following link: https://www.maximizemarketresearch.com/request-sample/100383/
Clinical Oncology Next-Generation Sequencing Market Key Players:
Major Contributors in the Clinical Oncology Next-Generation Sequencing Industry in North America:
1. Illumina, Inc.., San Diego, California, USA
2. Thermo Fisher Scientific, Inc., Waltham, Massachusetts, USA
3. Guardant Health, Inc., Redwood City, California, USA
4. PPacific Bioscience of California, Inc., Menlo Park, California, USA
5. Agilent Technologies, Inc., Santa Clara, California, USA
Leading players in the Europe Clinical Oncology Next-Generation Sequencing Market:
1. Qiagen N.V., Venlo, Netherlands
2. Roche Holdings AG (including Foundation Medicine), Basel, Switzerland
3. Oxford Nanopore Technologies Ltd., Oxford, United Kingdom
4. Genewiz Germany GmbH, Leipzig, Germany
5. Sophia Genetics SA, Saint-Sulpice, Switzerland
Key players driving the Asia-Pacific Clinical Oncology Next-Generation Sequencing Market:
1. Novogene Corporation, Beijing, China
2. BGI Group, Shenzhen, China
3. Takara Bio Inc., Kusatsu, Japan
4. MedGenome Labs Pvt. Ltd., Bengaluru, India
List of Contents : Clinical Oncology Next-Generation Sequencing Market
Part 01: Executive Summary
Part 02: Scope of the Clinical Oncology Next-Generation Sequencing Market Report
Part 03: Clinical Oncology Next-Generation Sequencing Market Landscape
Part 04: Clinical Oncology Next-Generation Sequencing Market Sizing
Part 05: Clinical Oncology Next-Generation Sequencing Market Segmentation by Type
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Discover the full report to understand the market’s future and develop strategies for your business: https://www.maximizemarketresearch.com/market-report/clinical-oncology-next-generation-sequencing-market/100383/
Key questions answered in the Clinical Oncology Next-Generation Sequencing Market are:
• What is Clinical Oncology Next-Generation Sequencing?
• What is the growth rate of the Clinical Oncology Next-Generation Sequencing Market?
• Which are the factors expected to drive the Clinical Oncology Next-Generation Sequencing market growth?
• What are the different segments of the Clinical Oncology Next-Generation Sequencing Market?
• What growth strategies are the players considering to increase their presence in Clinical Oncology Next-Generation Sequencing?
• What are the upcoming industry applications and trends for the Clinical Oncology Next-Generation Sequencing Market?
• What are the recent industry trends that can be implemented to generate additional revenue streams for the Clinical Oncology Next-Generation Sequencing Market?
• What major challenges could the Clinical Oncology Next-Generation Sequencing Market face in the future?
• What segments are covered in the Clinical Oncology Next-Generation Sequencing Market?
• Who are the leading companies and what are their portfolios in Clinical Oncology Next-Generation Sequencing Market?
• What segments are covered in the Clinical Oncology Next-Generation Sequencing Market?
• Who are the key players in the Clinical Oncology Next-Generation Sequencing market?
More Related Reports:
Asia Pacific UV LED Market https://www.maximizemarketresearch.com/market-report/asia-pacific-uv-led-market/195213/
North America UV LED Market https://www.maximizemarketresearch.com/market-report/north-america-uv-led-market/195277/
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
+91 96071 95908, +91 9607365656
